Malnutrition Often Seen in Patients Treated for IBD

2024-01-12
临床结果临床研究
FRIDAY, Jan. 12, 2024 -- Some patients seen in an inflammatory bowel disease (IBD) clinic screen positive for malnutrition, according to a research letter published online Nov. 20 in Gastro Hep Advances.
Aaron C. Viser, from the University of North Carolina at Chapel Hill, and colleagues used data from a multidisciplinary IBD clinic (June 7 to July 19, 2022) of 237 adult patients with confirmed Crohn disease or ulcerative colitis (UC) presenting for routine, in-person clinical care screened for malnutrition using the Malnutrition Screening Tool (MST).
The researchers found that the screening took two to three minutes per patient to administer, with 14 percent screening positive for malnutrition (Crohn disease: 15 percent; UC: 12 percent). Among IBD patients who screened positive for malnutrition, being a new consult; having a normal body mass index, active disease, and history of smoking; and taking corticosteroid or aminosalicylate medications were more common. The prevalence of a positive screen was higher (28 percent) among patients with active disease and lower (8 percent) among patients in remission. When adjusting for age and sex, IBD patients with active disease were more likely to screen positive for malnutrition versus those in remission (odds ratio [OR], 4.6; 95 percent confidence interval [CI], 2.1 to 10.2). A positive screen was also more likely among former smokers (OR, 2.4; 95 percent CI, 1.0 to 5.7) and current smokers (OR, 2.3; 95 percent CI, 0.4 to 12.3) compared with nonsmokers.
"The validated three-question MST could be easily implemented in routine clinical care in an IBD clinic with the aim to provide same-day dietitian support for patients at risk for malnutrition," the authors write.
One author disclosed ties to industry.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。